SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-212311"
 

Search: onr:"swepub:oai:DiVA.org:uu-212311" > Causes of Death and...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Causes of Death and Influencing Factors in Patients With Atrial Fibrillation A Competing-Risk Analysis From the Randomized Evaluation of Long- Term Anticoagulant Therapy Study

Marijon, Eloi (author)
Le Heuzey, Jean-Yves (author)
Connolly, Stuart (author)
show more...
Yang, Sean (author)
Pogue, Janice (author)
Brueckmann, Martina (author)
Eikelboom, John (author)
Themeles, Ellison (author)
Ezekowitz, Michael (author)
Wallentin, Lars (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
Yusuf, Salim (author)
show less...
 (creator_code:org_t)
2013
2013
English.
In: Circulation. - 0009-7322 .- 1524-4539. ; 128:20, s. 2192-2201
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background Atrial fibrillation is associated with increased mortality, but the specific causes of death and their predictors have not been described among patients on effective anticoagulant therapy. Methods and Results The Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial randomized 18113 patients (age, 71.59 years; male, 64%; CHADS(2) score, 2.11) to receive dabigatran or warfarin. Median follow-up was 2 years, and complete follow-up was achieved in 99.9% of patients. All deaths were categorized by the investigators using prespecified definitions followed by central adjudication. Overall, 1371 deaths occurred (annual mortality rate, 3.84%; 95% confidence interval [CI], 3.64-4.05). Cardiac deaths (sudden cardiac death and progressive heart failure) accounted for 37.4% of all deaths, whereas stroke- and hemorrhage-related deaths represented 9.8% of the total mortality. An examination of the causes of death according to dabigatran or warfarin showed that dabigatran significantly reduced vascular (embolism and hemorrhage-related) mortality (relative risk, 0.63; 95% CI, 0.45-0.88; P=0.007), whereas other causes of death were similar between treatments, including cardiac mortality (relative risk, 0.96; 95% CI, 0.80-1.15; P=0.638). The two strongest independent predictors of cardiac death in this population were heart failure (hazard ratio, 3.02; 95% CI, 2.45-3.73; P<0.0001), and prior myocardial infarction (hazard ratio, 2.05; 95% CI, 1.61-2.62; P<0.0001). Conclusions The majority of deaths are not related to stroke in a contemporary anticoagulated atrial fibrillation population. These results emphasize the need to identify interventions beyond effective anticoagulation to further reduce mortality in atrial fibrillation. 

Keyword

death
sudden
cardiac
embolism
heart failure
hemorrhage
mortality
stroke

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view